Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine

Michael PennickBiosciences Department, Shire Pharmaceutical Development Ltd, Basingstoke, UKAbstract: These studies investigated the absorption and metabolic conversion of lisdexamfetamine dimesylate (LDX), a prodrug stimulant that requires conversion to d-amphetamine for activity. Oral absorption o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Michael Pennick
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://doaj.org/article/50dcc49742e546ef94b5dfbec870a8c2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:50dcc49742e546ef94b5dfbec870a8c2
record_format dspace
spelling oai:doaj.org-article:50dcc49742e546ef94b5dfbec870a8c22021-12-02T02:45:58ZAbsorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine1176-63281178-2021https://doaj.org/article/50dcc49742e546ef94b5dfbec870a8c22010-06-01T00:00:00Zhttp://www.dovepress.com/absorption-of-lisdexamfetamine-dimesylate-and-its-enzymatic-conversion-a4556https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Michael PennickBiosciences Department, Shire Pharmaceutical Development Ltd, Basingstoke, UKAbstract: These studies investigated the absorption and metabolic conversion of lisdexamfetamine dimesylate (LDX), a prodrug stimulant that requires conversion to d-amphetamine for activity. Oral absorption of LDX was assessed in rat portal and jugular blood, and perfusion of LDX into isolated intestinal segments of anesthetized rats was used to assess regional absorption. Carrier-mediated transport of LDX was investigated in Caco-2 cells and Chinese hamster ovary (CHO) cells expressing human peptide transporter-1 (PEPT1). LDX metabolism was studied in rat and human tissue homogenates and human blood fractions. LDX was approximately10-fold higher in portal blood versus systemic blood. LDX and d-amphetamine were detected in blood following perfusion of the rat small intestine but not the colon. Transport of LDX in Caco-2 cells had permeability apparently similar to cephalexin and was reduced with concurrent PEPT1 inhibitor. Affinity for PEPT1 was also demonstrated in PEPT1-transfected CHO cells. LDX metabolism occurred primarily in whole blood (rat and human), only with red blood cells. Slow hydrolysis in liver and kidney homogenates was probably due to residual blood. The carrier-mediated absorption of intact LDX, likely by the high-capacity PEPT1 transporter, and subsequent metabolism to d-amphetamine in a high-capacity system in blood (ie, red blood cells) may contribute to the consistent, reproducible pharmacokinetic profile of LDX.Keywords: lisdexamfetamine dimesylate, LDX, prodrug, ADHD, absorption, Vyvanse Michael PennickDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2010, Iss Issue 1, Pp 317-327 (2010)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Michael Pennick
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
description Michael PennickBiosciences Department, Shire Pharmaceutical Development Ltd, Basingstoke, UKAbstract: These studies investigated the absorption and metabolic conversion of lisdexamfetamine dimesylate (LDX), a prodrug stimulant that requires conversion to d-amphetamine for activity. Oral absorption of LDX was assessed in rat portal and jugular blood, and perfusion of LDX into isolated intestinal segments of anesthetized rats was used to assess regional absorption. Carrier-mediated transport of LDX was investigated in Caco-2 cells and Chinese hamster ovary (CHO) cells expressing human peptide transporter-1 (PEPT1). LDX metabolism was studied in rat and human tissue homogenates and human blood fractions. LDX was approximately10-fold higher in portal blood versus systemic blood. LDX and d-amphetamine were detected in blood following perfusion of the rat small intestine but not the colon. Transport of LDX in Caco-2 cells had permeability apparently similar to cephalexin and was reduced with concurrent PEPT1 inhibitor. Affinity for PEPT1 was also demonstrated in PEPT1-transfected CHO cells. LDX metabolism occurred primarily in whole blood (rat and human), only with red blood cells. Slow hydrolysis in liver and kidney homogenates was probably due to residual blood. The carrier-mediated absorption of intact LDX, likely by the high-capacity PEPT1 transporter, and subsequent metabolism to d-amphetamine in a high-capacity system in blood (ie, red blood cells) may contribute to the consistent, reproducible pharmacokinetic profile of LDX.Keywords: lisdexamfetamine dimesylate, LDX, prodrug, ADHD, absorption, Vyvanse
format article
author Michael Pennick
author_facet Michael Pennick
author_sort Michael Pennick
title Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
title_short Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
title_full Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
title_fullStr Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
title_full_unstemmed Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
title_sort absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
publisher Dove Medical Press
publishDate 2010
url https://doaj.org/article/50dcc49742e546ef94b5dfbec870a8c2
work_keys_str_mv AT michaelpennick absorptionoflisdexamfetaminedimesylateanditsenzymaticconversiontodamphetamine
_version_ 1718402159798648832